Acronyms

DIN

Also found in: Wikipedia.
(redirected from Drug Identification Number)
Category filter:
AcronymDefinition
DINDeutsches Institut für Normung eV (German Institute for Standardization; similar to US ANSI)
DINDrug Identification Number
DINDigital Input
DINDinar (Yugoslavian national currency)
DINData Input
DINDo It Now (gaming/chat)
DINDissolved Inorganic Nitrogen
DINDigital Network
DINDeutsche Industrie Norm
DINDiscrete Input
DINDeutsche Industrie Normen
DINDocument Identification Number
DINDevelopment in Nigeria
DINDonor Identification Number
DINDirector Identification Number (India)
DINDivision Ingénierie Nucléaire (French: Nuclear Engineering Division; Electricité de France)
DINDoctors Independent Network
DINDarned If I Know
DINDefense Intelligence Network
DINData Identification Number
DINDefense Intelligence Notice
DINDesignee Information Network
DINDeutsche Industrial Norms (German standards agency)
DINDevice Identification Number
DINDepartment of Immigration and Naturalization
DINDivision des Installations Nucléaires (French: Division of Nuclear Installations; Autorité de Sûreté Nucléaire)
DINDangerous Incident Notification
DINDedicated Internet Network (private networks connected to the internet)
DINDynamic Instruction Number
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive
That total includes substances that are now regulated as drugs and are registered with a Drug Identification Number (DIN) as well as products that are unregistered.
Under The Food and Drugs Act, the branch can decide that a substance is a `drug' as soon as a health benefit is claimed by a manufacturer, a retailer, or if a substance has a "known pharmaceutical effect." Some of these products may be sold if manufacturers apply for a drug identification number (DIN), a costly process, but one which enables some limited claims to be made.
However, the then Health Protection Branch (HPB) in Canada granted several Drug Identification Numbers (DINs) for dried whole leaf feverfew (Tanacetum parthenium) products, with the specific claim of migraine prevention, if the criteria of botanical authentication of raw material and a minimum of 0.2% parthenolide were met.
There will be a transition period for the regulations that will span from two to six years--two years for site licensing and six years for products with drug identification numbers (DINs)--to allow manufacturers, labelers, packagers, importers and distributors time to meet the new requirements.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.